Peru - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPeru: Vaccine Market 2024
Vaccine Market Size in Peru
The Peruvian vaccine market declined markedly to $X in 2022, reducing by -20.3% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption, however, saw a remarkable increase. As a result, consumption attained the peak level of $X, and then reduced markedly in the following year.
Vaccine Exports
Exports from Peru
In 2022, shipments abroad of vaccines for human medicine increased by 90% to X kg, rising for the second consecutive year after three years of decline. Over the period under review, exports recorded a tangible expansion. The pace of growth appeared the most rapid in 2014 when exports increased by 428% against the previous year. The exports peaked at X kg in 2017; however, from 2018 to 2022, the exports failed to regain momentum.
In value terms, vaccine exports expanded sharply to $X in 2022. Overall, exports, however, recorded a abrupt downturn. The most prominent rate of growth was recorded in 2014 with an increase of 472% against the previous year. The exports peaked at $X in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.
Exports by Country
The Dominican Republic (X kg) and Colombia (X kg) were the main destinations of vaccine exports from Peru.
From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the Dominican Republic (with a CAGR of +60.0%).
In value terms, the Dominican Republic ($X) and Colombia ($X) appeared to be the largest markets for vaccine exported from Peru worldwide.
The Dominican Republic, with a CAGR of +35.3%, recorded the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review.
Export Prices by Country
The average vaccine export price stood at $X per ton in 2022, reducing by -40.8% against the previous year. Overall, the export price continues to indicate a abrupt curtailment. The most prominent rate of growth was recorded in 2013 an increase of 24% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2016; however, from 2017 to 2022, the export prices remained at a lower figure.
Average prices varied noticeably for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Colombia ($X per ton), while the average price for exports to the Dominican Republic totaled $X per ton.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Bolivia (+47.5%), while the prices for the other major destinations experienced a decline.
Vaccine Imports
Imports into Peru
Vaccine imports into Peru contracted to X tons in 2022, which is down by -8.5% against 2021. Over the period under review, total imports indicated a pronounced expansion from 2012 to 2022: its volume increased at an average annual rate of +2.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +2.7% against 2020 indices. The growth pace was the most rapid in 2014 with an increase of 43%. Imports peaked at X tons in 2019; however, from 2020 to 2022, imports remained at a lower figure.
In value terms, vaccine imports fell rapidly to $X in 2022. In general, imports, however, enjoyed a remarkable increase. The growth pace was the most rapid in 2021 when imports increased by 99% against the previous year. As a result, imports attained the peak of $X, and then contracted dramatically in the following year.
Imports by Country
South Korea (X tons), India (X tons) and France (X tons) were the main suppliers of vaccine imports to Peru, with a combined 44% share of total imports. Belgium, the United States, Argentina and Germany lagged somewhat behind, together comprising a further 29%.
From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Argentina (with a CAGR of +79.0%), while imports for the other leaders experienced more modest paces of growth.
In value terms, the United States ($X) constituted the largest supplier of vaccines for human medicine to Peru, comprising 31% of total imports. The second position in the ranking was held by Belgium ($X), with a 14% share of total imports. It was followed by South Korea, with an 8.3% share.
From 2012 to 2022, the average annual rate of growth in terms of value from the United States amounted to +22.1%. The remaining supplying countries recorded the following average annual rates of imports growth: Belgium (-0.2% per year) and South Korea (+10.1% per year).
Import Prices by Country
The average vaccine import price stood at $X per ton in 2022, falling by -17.9% against the previous year. Over the period under review, the import price, however, posted strong growth. The growth pace was the most rapid in 2021 when the average import price increased by 77%. As a result, import price reached the peak level of $X per ton, and then declined rapidly in the following year.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (+15.1%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the vaccine market in Peru. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Peru
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Peru
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the vaccine market in Asia.
This report provides an in-depth analysis of the vaccine market in the U.S..
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the vaccine market in the EU.
This report provides an in-depth analysis of the global vaccine market.